Alternative to animal testing for drug development
We’re developing the most advanced technological platform for predicting the impact of molecules (drug, biologics, endocrine disruptor, cosmetic) on the human body to better treat pathologies (orphan diseases, cancer, bacterial resistance, virus).

Expertise
Cherry Biotech has developed a unique multidisciplinary scientific and technical expertise at your service!

- 3D cell culture
- Immunocompetent in vitro
- Cell Biology
- Cancer biology
- Tissue engineering

- Microfluidics
- Microscopy
- Sensing
- Bio sensor
- Nano technology
- Chemical sensor

- Electronic & optical sensor
- Microphysiological system (MPS)
- Artificial intelligence
Our Solutions
Cherry Biotech offers a complex range of products and services, including CRO 3D in-vitro activity, CubiX microphysiological system, and CherryTemp temperature control systems. These solutions aim to help laboratories and pharma companies accelerate their drug development process with greater accuracy and precision, while providing alternatives to animal testing. By leveraging innovative technologies and expertise, we offer our clients a competitive advantage in the field of 3D in-vitro research and drug development.
3D In Vitro Contract Research Organization (CRO) Service
We provide both standard and customized in vitro studies that can be used to screen your new therapeutic candidates, explore the mechanisms of action, and accelerate the design of clinical trials.
Our range of services is particularly suitable for drug developers who require rapid access to organoids, 3D cell-cultures technology but do not wish to invest in their own equipment.


CubiX Platform - A Complex Representation of Human's Biology
- From Organ on Chip to Multi-Organ on Well
- Compatible with Standard Multiwell Plates
- Vascularized immunocompetent organoids
CherryTemp Enables Utra-Fast Temperature Shifts in the 5-45°C
- 10s temperature shift
- 0,1°C precision
- Stability: T°C room compensation

start a project with us
They Trust Us















